Experience of dupilumab treatment in inherited epidermolysis bullosa: A short series

J Am Acad Dermatol. 2024 Aug;91(2):373-376. doi: 10.1016/j.jaad.2024.04.037. Epub 2024 Apr 26.

¹ Dermatology Department, Necker-Enfants Malades Hospital, Expert Centre for Genodermatoses MAGEC-Necker, Filière Maladies Rares Dermatologiques (FIMARAD), APHP, Paris-Cité University, Paris, France. Electronic address: nathalia.bellon@aphp.fr.
² Dermatology Department, Necker-Enfants Malades Hospital, Expert Centre for Genodermatoses MAGEC-Necker, Filière Maladies Rares Dermatologiques (FIMARAD), APHP, Paris-Cité University, Paris, France.
³ Genomic Medecine of Rare Diseases, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Inserm UMR1151, CNRS UMR8253, Team Immunoregulation and Immunopathology, Université Paris Cité, Paris, France.

No abstract available

Keywords: biologics; cytokines; dupilumab; genodermatoses; inflammation; inherited epidermolysis bullosa; pediatric dermatology; pruritus.

Publication types